BPMC - Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q1 2021 Results - Earnings Call Transcript

Blueprint Medicines Corporation (BPMC) Q1 2021 Earnings Conference Call April 29, 2021, 2021 08:30 ET Company Participants Kristin Hodous - Senior Manager, Investor Relations Jeff Albers - Chief Executive Officer Christy Rossi - Chief Commercial Officer Becker Hewes - Chief Medical Officer Mike Landsittel - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Marc Frahm - Cowen & Company Dane Leone - Raymond James Michael Schmidt - Guggenheim David Lebowitz - Morgan Stanley Chris Raymond - Piper Sandler Reni Benjamin - JMP Securities David Nierengarten - Wedbush Securities Peter Lawson - Barclays Brad Canino - Credit Suisse Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Kristin Hodous, with Blueprint Medicines. Thank

For further details see:

Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q1 2021 Results - Earnings Call Transcript